Publications

2019

scSLAM-seq reveals core features of transcription dynamics in single cells, Erhard F., Baptista M.A., Krammer T. Hennig T. ,Lange M., Arampatzi P., Jürges C.S., Theis F.J., Saliba A.E., Dölken L.; Nature 571, 419-423 (2019). https://www.nature.com/articles/s41586-019-1369-y

The complex of MCMV proteins and MHC class I evades NK cell control and drives the evolution of virus-specific activating Ly49 receptors, Železnjak J., Juranić Lisnić V., Popović B., Lisnić B., Babić M., Halenius A., L’Hernault A., Lenac Roviš T., Hengel H., Erhard F., Redwood A.J., Vidal S.M., Dölken L., Krmpotić A., Jonjić S., Journal of Experimental Medicine 216, 1809–1827 (2019). https://rupress.org/jem/article/216/8/1809/120585

Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models, Lübke M., Spalt S., Kowalewski D.J., Zimmermann C., Bauersfeld L., Nelde A., Bichmann L., Marcu A., Peper J.K., Kohlbacher O., Walz J.S., Le-Trilling V.T.K., Hengel H., Rammensee H.-G., Stevanović S., Halenius A., Journal of Experimental Medicine 217, e20191164 (2019). https://rupress.org/jem/article/217/3/e20191164/133529/Identification 

2020

Differential effects of Belatacept on virus-specific memory versus de novo allo-specific T cell responses of kidney transplant recipients and healthy donors, Kühne J.F., Neudörfl C., Beushausen K., Keil J., Malysheva S., Wandrer F., Haller H., Messerle M., Blume C., Neuenhahn M., Schlott F., Hammershmidt W., Zeidler R., Falk C.S., ScienceDirect, 61, 101291 (2020). https://www.sciencedirect.com/science/article/pii/S0966327419301674 

How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation, Einsele H., Ljungmann P., Boeckh M., Blood 135, 1619–1629 (2020). https://ashpublications.org/blood/article/135/19/1619/452747/How-I-treat-CMV-reactivation-after-allogeneic

Identification of the Cryptic HLA-I Immunopeptidome, Erhard F., Dölken L., Schilling B., Schlosser A., AACR Publications 8, 1018-1026 (2020).
https://cancerimmunolres.aacrjournals.org/content/8/8/1018 

 

2021

COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses. Bonifacius A., Tischer-Zimmermann S., Dragon A.C., Gussarow D., Vogel A., Krettek U., Gödecke N., Yilmaz M., Kraft A.R.M., Hoeper M.M., Pink I., Schmidt J.J., Li Y., Welte T., Maecker-Kolhoff B., Martens J., Berger M.M., Lobenwein C., Stankov M.V., Cornberg M., David S., Behrens G.M.N., Witzke O., Blasczyk R., Eiz-Vesper B., Immunity, 54: 340–354. (2021) https://www.sciencedirect.com/science/article/pii/S1074761321000315?via%3Dihub 

Cytomegalovirus restricts ICOSL expression on antigen-presenting cells disabling T cell co-stimulation and contributing to immune evasion. Angulo G., Zeleznjak J., Martínez-Vicente P., Puñet-Ortiz J., Hengel H., Messerle M., Oxenius A., Jonjic S., Krmpotic A., Engel P., Angulo A., Elife. 18;10:e59350. doi: 10.7554/eLife.59350 (2021) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840182/

Viral infection of the ovaries compromises pregnancy and reveals innate immune mechanisms protecting fertility. Tomac J, Mazor M, Lisnić B, Golemac M, Kveštak D, Bralić M, Bilić Zulle L, Brinkmann MM, Dölken L, Reinert LS, Paludan SR, Krmpotić A, Jonjić S, Juranić Lisnić V.. Immunity. 54(7):1478-93.e6. doi: 10.1016/j.immuni.2021.04.020. (2021) https://www.sciencedirect.com/science/article/abs/pii/S1074761321001825 

Genetic risk of CMV reactivation? Einsele H, Kraus S. Blood. Oct 28;138(17):1516-1517. (2021) https://ashpublications.org/blood/article/138/17/1516/477404/Genetic-risk-of-CMV-reactivation

A CMV sero-donor to avoid T cell inflation. Einsele H, Doelken L. Blood. (2021); accepted.